title: Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
abstract: Calcium oxalate (CaOx) and calcium phosphate (CaP) crystals do not precipitate in large amounts in normal urine despite considerable supersaturation (SS), partly because urine inhibits crystal nucleation, aggregation, and growth. In normal rats and rats bred for hypercalciuria (GHS), we varied SS by varying calcium intake to test the hypothesis that increased SS might deplete inhibitors and reduce inhibition of crystal formation. In normal rats when compared to a low calcium diet (0.02% Ca), a high calcium diet (1.2% Ca) raised the SS of CaOx from 0.8 to 8.2. The high calcium diet also raised the upper limit of metastability (ULM) of CaOx (the SS at which crystals form in urine) from 11.8 to 36. In GHS rats, diet change altered CaOx SS from 1.5 to 12, and ULM from 17 to 50 (all differences, P < 0.001). Because ULM rose with SS, the increased SS had little potential to increase CaOx stone risk. For CaP, however, SS rose from 0.6 to 2.4 and 1.1 to 8 in normal and GHS rats (P < 0.001 for both), respectively, whereas ULM for CaP did not increase significantly (8 vs. 7 and 7 vs. 11; P = NS, both changes). Therefore, CaP SS rose close to the ULM, posing a high stone risk. The stones formed by these rats are composed of CaP. Increasing CaOx SS by diet raises ULM for CaOx thereby offsetting the risk of CaOx stones in rats.
authors.affiliation: Nephrology Program, University of Chicago, Illinois, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Asplin
authors.forename: D A
authors.initials: DA
authors.lastname: Bushinsky
authors.forename: W
authors.initials: W
authors.lastname: Singharetnam
authors.forename: D
authors.initials: D
authors.lastname: Riordon
authors.forename: J H
authors.initials: JH
authors.lastname: Parks
authors.forename: F L
authors.initials: FL
authors.lastname: Coe
mesh_terms: D000818:Animals; D002118:Calcium / Q000652:urine*; D002129:Calcium Oxalate / Q000737:chemistry / Q000652:urine; D002130:Calcium Phosphates / Q000737:chemistry / Q000652:urine; D002136:Calcium, Dietary / Q000008:administration & dosage / Q000009:adverse effects; D011232:Chemical Precipitation; D003460:Crystallization; D005260:Female; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D014545:Urinary Calculi / Q000737:chemistry / Q000209:etiology* / Q000652:urine
chemical_list: D002130:Calcium Phosphates; D002136:Calcium, Dietary; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D002129:Calcium Oxalate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D002118:Calcium